A Phase 3, Randomized, Double-blind, Placebo and Adalimumab-controlled Study to Evaluate the Efficacy and Safety of Filgotinib in Subjects with Active Psoriatic Arthritis Who Are Naïve to Biologic DMARD Therapy.
Year: 2020
Type: Musculoskeletal
Phase: III
Indication: Psoriatic Arthritis
A randomized, double-blind, placebo-controlled study of the safety and efficacy of AA4500 for the treatment of adhesive capsulitis of the shoulder.
Year: 2014
Type: Musculoskeletal
Phase: IIb
Indication: Other
An Open-label Historically Controlled Study to Assess the Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects with Multiple Dupuytren’s Contractures with Palpable Cords.
Year: 2012
Type: Musculoskeletal
Phase: IIIb
Indication: Other
Dose-Ranging Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Participants with Active Rheumatoid Arthritis despite Ongoing Methotrexate Therapy.
Year: 2010
Type: Musculoskeletal
Phase: II
Indication: Rheumatoid Arthritis
A Study to Compare the Preference for Two Contrasting Paracetamol Formulations In The Management of Osteoarthritis Pain.
Year: 2008
Type: Musculoskeletal
Phase: IV
Indication: Knee Osteoarthritis
A Multi-Centre, Randomised, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study to Investigate the Efficacy, Safety and Tolerability of AD 337 in the Treatment of Fibromyalgia in Female Subjects.
Year: 2007
Type: Musculoskeletal
Phase: II
Indication: Fibromyalgia
A Randomised Double-Blind, Placebo-and-Active-Control, Parallel-arm, Phase III Trial with Controlled Adjustment of Dose to Evaluate the Efficacy and Safety of CG5503 Extended –Release (ER) in Subjects with Moderate to Severe Pain Due to Osteoarthritis of the Knee.
Year: 2008
Type: Musculoskeletal
Phase: III
Indication: Knee Osteoarthritis
A Randomized, Double Blind, Parallel-Group Study of Cardiovascular Safety in Osteoarthritis or Rheumatoid Arthritis Patients with or At High Risk for Cardiovascular Disease Comparing Celecoxib with Naproxen and Ibuprofen.
Year: 2011
Type: Musculoskeletal
Phase: IV
Indication: Rheumatoid Arthritis
A Double Blind, Randomised, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients with Osteoarthritis of the Knee.
Year: 2012
Type: Musculoskeletal
Phase: II
Indication: Knee Osteoarthritis
A Multi centre, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated with Osteoarthritis in the Knee.
